ABSOLUTE RISK (SCORE 2005) IN OUTWARD-PATIENTS WITH ARTERIAL HYPERTENSION AND WITH/WITHOUT METABOLIC SYNDROME. INTERGENDER DIFFERENCES

被引：0
|
作者：
Kosmalova, V. [1 ]
Polak, M. [1 ]
Turek, P. [1 ]
Lietava, J. [1 ]
机构：
[1] Univ Hosp, Dept Internal Med 2, Bratislava, Slovakia
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379948.09834.06
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E572 / E572
页数：1
相关论文
共 11 条
  • [1] Treatment of patients with arterial hypertension and metabolic syndrome. The role of the combination drugs
    Shilov, A. M.
    Dulaeva, M. S.
    Osia, A. O.
    Lishuta, A. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (01) : 92 - 98
  • [2] Renal pathology features in arterial hypertension patients with and without metabolic syndrome
    Sharipova, G. Kh
    Chazova, I. E.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2008, (06): : 4 - 9
  • [3] The risk of metabolic syndrome in patients with arterial hypertension in relation to psychological and biological risk factors
    Nikolic, Gordana
    Tasic, Ivan
    Zikic, Olivera
    Tosic-Golubovic, Suzana
    Stojanovic, Nikola
    Simonovic, Maja
    Kostic, Jelena
    VOJNOSANITETSKI PREGLED, 2021, 78 (07) : 716 - 722
  • [4] Carotid intima-media thickness in arterial hypertension patients with and without metabolic syndrome
    Sharipova, G. Kh.
    Balakhonova, T. V.
    Mychka, V. B.
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (02): : 102 - 108
  • [5] No differences in arterial stiffness or endothelial function in essential hypertensive patients with or without the metabolic syndrome
    Plantinga, Y.
    Ghiadoni, L.
    Magagna, A.
    Salvetti, G.
    Taddei, S.
    Salvetti, A.
    JOURNAL OF HYPERTENSION, 2006, 24 : S146 - S146
  • [6] Cardiovascular Risk Stratification in Patients with Metabolic Syndrome Without Diabetes or Cardiovascular Disease: Usefulness of Metabolic Syndrome Severity Score
    Masson W.
    Epstein T.
    Huerín M.
    Lobo L.M.
    Molinero G.
    Angel A.
    Masson G.
    Millán D.
    De Francesca S.
    Vitagliano L.
    Cafferata A.
    Losada P.
    High Blood Pressure & Cardiovascular Prevention, 2017, 24 (3) : 297 - 303
  • [7] Effects of irbesartan on brain perfusion in patients with arterial hypertension with and without metabolic syndrome and type 2 diabetes mellitus
    Mamyrbaeva, K. M.
    Mychka, V. B.
    Sergienko, V. B.
    Chazova, I. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 865 - 865
  • [8] TELMISARTAN PREVENTED NEW CASES DIABETES MELLITUS (DM) IN PATIENTS WITH ARTERIAL HYPERTENSION (AH) AND METABOLIC SYNDROME (MS) WITHOUT DM
    Rekovets, O. L.
    Sirenko, Y. M.
    Pavluk, E. A.
    Savitskiy, S. Y.
    Primak, G. F.
    Vashchilko, A. S.
    JOURNAL OF HYPERTENSION, 2009, 27 : S86 - S86
  • [9] Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population
    Aksu, Ayse Esra Koku
    Saracoglu, Zeynep Nurhan
    Metintas, Selma
    Sabuncu, Ilham
    Cetin, Yildiz
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 17 (01): : 66 - 72
  • [10] CORRELATION RELATIONSHIP HOMA INDEX WITH BLOOD PRESSURE, HEART RATE AND LIPID IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME WITHOUT DIABETES TREATED DIFFERENT BETA BLOCKERS
    Rekovets, Oksana
    Sirenko, Yuriy
    Torbas, Olena
    Mironova, Olga
    Primak, Galina
    Vashchylko, Alla
    Pavlyuk, Evgenia
    Savitskiy, Sergey
    Granich, Vladimir
    Sidorenko, Petro
    Polishchuk, Sergey
    JOURNAL OF HYPERTENSION, 2016, 34 : E349 - E349
12